Corporate Governance

The South African National Blood Service is a non-profit organisation, which serves the public through services procured from the public. SANBS must therefore operate within a sound corporate governance framework in order to give all its stakeholders the assurance that the organisation is operated, managed and governed in a manner which is appropriate to a non-profit organisation.

The corporate governance landscape in South Africa has changed significantly during the past decade, as a result of corporate governance scandals in both the public and private domain. The result of these governance catastrophes was the publication of the Third King Report on Corporate Governance (King 3), in addition to the promulgation of the Companies Act of 2008.

When the 2001 King Report was issued, the SANBS Board recognised that various changes were required to the SANBS governance structure in order to comply with the report. These changes were implemented as appropriate. With the implementation of the King 3 Report and 2008 Companies Act, the SANBS Board must realise that corporate governance is a continuously evolving process. Therefore, the Board must be prepared to reassess its corporate governance framework on a regular basis, in order to take cognisance of changes to SANBS’ internal and external environment, as this will be the only way of ensuring that SANBS remains sustainable into the future.

SANBS has now embarked upon a process to ensure that it complies with:

  • The requirements of the Companies Act 2008
  • The requirements of the King 3 report
  • All relevant legislation, and
  • Appropriate codes of good practice

The Board recognises that any processes implemented must be flexible to ensure that SANBS is able to respond swiftly and appropriately to the challenges of the health services sector.

Should you have tip-offs, please note that you may utilise the intranet or 0800 20 40 75
or email





Dr Jonathan Louw
Chief Executive Officer

Dr Louw joins SANBS with a wealth of healthcare knowledge both from a medical and commercial point of view and is an experienced CEO. In 2017 he founded Healthwyse Consulting and prior to this, he was MD at the Abraaj Group (a Dubai-based private equity investment company). Dr Louw was at JSE-Listed Adcock Ingram and Tiger brands from 2001 to 2014, serving in a variety of capacities from New Business Development, MD of Pharmaceuticals (2003 to 2006) and then Chief Executive at Adcock Ingram (2006 to 2014). He has an MB.ChB (1993) and an MBA (1999), both from the University of Cape Town.


Dr. Jackie Thomson
Medical Director

Dr Thomson, who is a highly respected doctor in the field of Haematology has spearheaded a culture of excellence in transfusion medicine not only at SANBS but throughout the South African medical industry. She obtained her MBCHB from Stellenbosch University in 1996 and followed it up with a specialisation in internal medicine with her MMed in 2001. In 2005 she was awarded with a certificate in Haematology from the South African College of Medicine. Dr Thomson serves as a director on numerous other boards including the South African Bone Marrow Registry and the South African Stem Cells Transplant Society. She serves on the SANBS Clinical Governance and Risk sub-committees.

Board of Directors


Ms. Getty Simelane
Chairman of the Board

Ms Simelane is a passionate advocate for blood transfusion heads up the SANBS Board of directors. Among other qualifications, she has a BA in Social Work from the University of Zululand, which she obtained in 1981, a Master’s Degree in Philosophy from the University of Bath in the United Kingdom and completed the Executive Development Programme at the Kellogg Business School in the USA in 1993. She serves as the Chairperson for the Governance Social and Ethics Committee and is also a member of the HR and Remuneration Committee.


Dr. Patricia Knox
Non-Executive Donor Director

Dr Knox has had a long-standing relationship with SANBS and has been involved with South African Blood transfusion for decades. She is an internationally respected authority in blood transfusion and is a consultant for the American Association of Blood Banks and is the Chair of the African Society of Blood Transfusion. She serves as the chair of the Clinical Governance Committee and is also a member of the SANBS Risk sub-committee.


Ms. Ansie Ramalho
Non-Executive Donor Director

Ms Ramalho is a lawyer by training and believes that corporate governance can and should be harnessed for the benefit of the economy, society and the natural environment. She obtained her B.Juris from UNISA in 1988 and her B.Legum in 1991. She has also specialised in Insolvency Law and was the appointed King IV Project Lead with responsibility for the successful finalisation of the King IV Report on Corporate Governance for South Africa, 2016. She serves on a number of SANBS Sub-committees including the audit committee, Governance Social and Ethics Committee and is also a member of the HR & Remuneration Committee. Furthermore she chairs the SANBS Risk sub-committee.


Mr. Rob Theunissen
Non-Executive Donor Director

Mr Theunissen is an experienced self-employed consultant with significant experience as a non-executive board director in the private and public sectors. He has been involved with SANBS for many years and his qualifications as a chartered accountant and registered auditor have stood him in excellent stead while serving on the SANBS board. He is a member of the SANBS sub-committees for Audit, Nomination and Clinical Governance.


Mr. Rodney Brand
Non-Executive Donor Director

Mr Brand started his relationship with blood transfusion during the days of the Natal Blood Service. He has served the SANBS board in numerous capacities and has been critical to many of the decisions relating the success of the business. He is also a member of the South African Institute for Chartered Accountants. He serves as a member of the SANBS sub-committees for Audit, Nomination and Clinical Governance.


Ms Morongwe Malebye
Non-Executive Director

Ms Malebye is a founder and member of an engineering company and has more than 20 years experience in Engineering and Asset management. She has a Masters degree in Business Administration, and a MSc from Witwatersrand University. She also obtained a Project Management Diploma in 1996 after she graduated in Mechanical Engineering from the University of Cape Town in 1995. Together with other engineers and women, she has executed Renewable Energy multimillion projects in townships across South Africa while providing training and skilling of unemployed youth and women.


Prof. Vanessa Moodley
Independent Non-Executive Director

Professor Moodley, a highly respected haematologist, is a member of professional bodies such as the South African Society of Haematology, the Haematology Expert Committee and Clinical Pathology Expert Committee. She is also Head for the Discipline of Haematology at the University of Limpopo’s MEDUNSA Campus. Prof Moodley obtained her MBCHB from the University of Cape Town and followed it with her MMED in Haematological Pathology, which she passed cum laude in 2004. Prof Moodley serves as the Chairperson of the SANBS Nomination sub-committee and is also a member of the Clinical Governance sub-committee.


Prof. William Gumede
Independent Non-Executive Director

William Gumede is Associate Professor, School of Governance at the University of the Witwatersrand. During the anti-apartheid struggle, Gumede held several leadership positions in South African student, civics and trade union movements. He was a political violence mediator and area coordinator for the National Peace Committee during the multiparty negotiations for a democratic South Africa and was seconded to South Africa’s Truth and Reconciliation Commission. His string of international qualifications include a joint degree from Utrecht, Aarhus and Cardiff Universities, a Masters from the University of the Witwatersrand and a qualification in Investment Banking from New York University. He serves as the chair of the SANBS Sub-committee for HR and Remuneration and is a member of the Audit as well as Governance Social and Ethics Committees.